Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension
Status:
Terminated
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to test the hypothesis that hydroxyurea is effective for the
specific treatment of secondary pulmonary hypertension found on screening in children and
young adults with sickle cell disease.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Ann & Robert H Lurie Children's Hospital of Chicago